Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination
- PMID: 25600703
- DOI: 10.1111/pin.12253
Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination
Abstract
We classified ipsilateral breast tumor recurrences (IBTRs) based on strict pathological rules. Ninety-six women who were surgically treated for IBTR were included. IBTRs were classified according to their origins and were distinguished based on strict pathological rules: relationship between the IBTR and the primary lumpectomy scar, surgical margin status of the primary cancer, and the presence of in situ lesions of IBTR. The prognosis of these subgroups were compared to that of new primary tumors (NP) in the narrow sense (NPn) that occurred far from the scar. Distant-disease free survival of IBTR that occurred close to the scar with in situ lesions and a negative surgical margin of the primary cancer (NP occurred close to the scar, NPcs) was similar to that of NPn. In contrast, IBTR that occurred close to the scar without in situ lesions (true recurrence (TR) that arose from residual invasive carcinoma foci, TRinv) had significantly poorer prognosis than NPn. IBTR that occurred close to the scar with in situ lesions and a positive surgical margin of the primary cancer (TR arising from a residual in situ lesion, TRis) had more late recurrences than NPcs. Precise pathological examinations indicated four distinct IBTR subtypes with different characteristics.
Keywords: breast cancer; breast-conserving surgery; ipsilateral breast tumor recurrence; new primary tumor; true recurrence.
© 2015 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.
Similar articles
-
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104. Breast Cancer. 2005. PMID: 15858440
-
True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):409-17. doi: 10.1016/j.ijrobp.2010.05.063. Epub 2011 Feb 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 21288654
-
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.Cancer. 2002 Nov 15;95(10):2059-67. doi: 10.1002/cncr.10952. Cancer. 2002. PMID: 12412158
-
Ipsilateral breast tumor recurrence after breast-conserving therapy.Expert Rev Anticancer Ther. 2010 Aug;10(8):1229-38. doi: 10.1586/era.10.87. Expert Rev Anticancer Ther. 2010. PMID: 20735309 Review.
-
True local recurrences do not metastasize.Cancer Metastasis Rev. 2011 Jun;30(2):161-76. doi: 10.1007/s10555-011-9275-2. Cancer Metastasis Rev. 2011. PMID: 21267770 Review.
Cited by
-
Invasive Cancer Confined to the Nipple of the Conserved Breast: A Case Report.Case Rep Oncol. 2020 Sep 21;13(3):1125-1130. doi: 10.1159/000510309. eCollection 2020 Sep-Dec. Case Rep Oncol. 2020. PMID: 33082758 Free PMC article.
-
Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.Ann Surg Oncol. 2018 Jan;25(1):154-163. doi: 10.1245/s10434-017-6209-4. Epub 2017 Nov 1. Ann Surg Oncol. 2018. PMID: 29094250 Free PMC article.
-
Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma.J Breast Cancer. 2022 Aug;25(4):288-295. doi: 10.4048/jbc.2022.25.e36. J Breast Cancer. 2022. PMID: 36031753 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous